The consequences of Big Science’s bad bet…

Minimal research into coronaviruses and no drugs or vaccines in the pipeline.

In a prior post, we channeled a report titled “The Road Not Traveled” by investigative reporter Christine Dolan.

For details, see: 15 years ago, scientists bet that the next pandemic would NOT be a coronavirus and Why the bad bet?

In a nutshell, Dolan concludes that circa 2003:

The scientific world bet that the next big pandemic would emanate from a more traditional flu and not a coronavirus like Sudden Acute Respiratory Syndrome (SARS) or Middle East Respiratory Syndrome (MERS).

Obviously, that bet proved wrong … deadly wrong!

And, the implication of the bad bet:

“Although coronaviruses have been recognized as human pathogens for about 50 years, no effective treatment strategy has been developed.”

The fundamental reason: economics.


To understand the economics, Dolan channels former Health and Human Service Secretary Tom Price who says:

“One must understand the economics and psychology of private and government medical research.”

One-time treatments that have no long-term commercial market don’t excite pharmaceutical companies in the business of making profits.

And federal scientists always like jumping to the next big viral fire instead of finishing work on an earlier outbreak that fizzled like SARS.

“The extent of SARS was relatively small and short-lived. Once a (pandemic) threat passes, there is no economic incentive for pharmaceutical companies  and governmental research attention moves in a different, seemingly more urgent, direction.”


So what’s the answer?

Dolan reports that In October 2019, just several weeks before COVID-19 erupted in Wuhan, China, the Gates Foundation, the World Economic Summit, and John Hopkins Center for Health Security hosted a pandemic response simulation in New York City.

Among their key recommendations:

“Governments should provide more resources and support for the development and surge manufacturing of vaccines, therapeutics, and diagnostics that will be needed during a severe pandemic.”


Coming: “Managing the Impact of Pandemic Influenza Through Vaccine Innovation”

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: